Durham University’s New Enterprise Zone Opens its Doors at NETPark
Orbit, a new business accommodation space hosted by Durham University, has opened a new facility in NETPark, one of the UK’s leading science and technology parks.
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
Wesana Health announced its commitment to fund an initial US $1.5 million to assess the viability of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI).
Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction
Awakn Life Sciences Corp. has announced that it has received ethical committee approval and has initiated recruitment for the first-ever study investigating ketamine in gambling addiction.
Origin Therapeutics Launches To Fund Emerging Psychedelics Companies
Origin Therapeutics Holdings Inc. an actively managed investment issuer focused on making equity investments in psychedelics-related companies, is pleased to announce its launch.
Noldus Early-Career Software Grant
Noldus Information Technology is seeking proposals from North American researchers from all disciplines of behavioral science research.
Cryopreservation Media helps in Development of a Cell Therapy for Parkinson’s Disease
AMSBIO reports upon a publication that cites how its STEM-CELLBANKER® animal-free cryopreservation media has played a role in the development of a cell therapy for Parkinson’s Disease that will soon be going into clinical trials.